After a lengthy downturn, renewed optimism is building among young drugmakers and their backers as a new funding wave takes shape, said Santé Ventures’ Omar Khalil.

Despite world-class AI-biotech research, a Nobel Prize-winning protein design lab and proximity to global AI expertise, Washington's life sciences sector is still learning to tell its story.

The funding, which ranks as one of the largest of its kind for a China-based drug startup, will support a portfolio of ...

Gotham Biotech’s lease at 6 Main St. in Gray is a straight shot to the highway, an important consideration for overnight shipping of the perishable products. PHOTO / COURTESY COLLIERS OF MAINE A ...

When Neal Piper’s son, Noah, rang the bell at UVA Children’s Hospital in December 2020, it signaled the end of grueling chemotherapy treatments connected to beeping monitors and intravenous tubes.

Artificial intelligence and biotech are two of the sectors that have been able to buck the current sluggish pace of venture capital spending. So it’s not surprising a startup at the intersection of ...

Seoul-based Illimis Therapeutics has raised 58 billion won ($42 million) to fund its research into treatments for Alzheimer’s disease and expand into immune diseases. The Series B was led by Korean ...

Slate Medicines, a new Raleigh biotechnology company developing treatments for migraine and headache disorders, has announced a $130 million Series A round of financing to advance its novel therapy.

India's Biotechnology Industry Research Assistance Council, BIRAC, marked its 14th Foundation Day. It has significantly boosted India's biotech startup ecosystem. BIRAC has provided substantial ...

Advent Therapeutics is developing vitamin A therapies aimed at preventing chronic lung disease in premature babies.

BIRAC celebrated its 14th Foundation Day, highlighting its role in catalysing India's biotech startup revolution. The council ...